BMRA Biomerica Inc.

Biomerica Inc develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions.

As of 10/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  12,511,210
Average volume:  6,319,536
Market cap:   $60,178,920
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09061H307
ISIN:        US09061H3075
Valuation   (See tab for details)
PE ratio:   -8.57
PB ratio:   6.19
PS ratio:   8.22
Return on equity:   -55.42%
Net income %:   -66.67%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy